Company profile
Cryogatt Systems Limited
Cryogatt Systems Ltd | Cryogatt
New and retrofit solutions available, join leading experts and start using the Cryogatt Systems in your laboratory. Enquire for a no obligation quote today.
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Capital Allotment Shares
CapitalSH01 | Transaction MzQzNzU1OTUxN2FkaXF6a2N4
Published 30 Sep 2024 09:45
Capital Allotment Shares
CapitalSH01 | Transaction MzQzNTU5MTk0M2FkaXF6a2N4
Published 13 Sep 2024 14:16
Capital Allotment Shares
CapitalSH01 | Transaction MzQzMTg2NjE1MWFkaXF6a2N4
Published 13 Aug 2024 13:03
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzQzMTg2NTgxOGFkaXF6a2N4
Published 13 Aug 2024 13:02
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzIzNzI2MTEyM2FkaXF6a2N4
Published 15 Aug 2024 07:07
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzE0NjQxNjUyMWFkaXF6a2N4
Published 15 Aug 2024 07:07
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Standard Approach to atMP tissue ColLEction (Sample)
1 Apr 2021 to 31 Mar 2022
RFID to enable ATMP Manufacturing, Cryogenic Supply Chain Scale-Up and Productivity Gains
1 Jun 2020 to 30 Nov 2020
no public description
RFID to enable ATMP Manufacturing, Cryogenic Supply Chain Scale-Up and Productivity Gains
1 Oct 2018 to 31 Mar 2022
"Manufacture of cell and gene therapies (also known as Advanced Therapy Medicinal Products or ATMPs) is highly labour intensive and technically complex requiring a three-phase process: Primary Manufacturing (production), Secondary Manufacturing (storage, packing and distribution) and Final Preparation (delivery and patient administration), which due to th...
Automation of Cell Therapy Cryostorage Processes and Future Manufacturing Facilities
1 Feb 2016 to 30 Apr 2017
Cell therapy manufacture is currently labour intensive, which presents a significant barrier to the growth of the industry. This project will introduce new manufacturing processes in to the industry which will drive down costs, improve quality and open up new markets. The project will develop and demonstrate key technology components required to automate ...